About this series
The AAPS Advances in the Pharmaceutical Sciences Series, published in partnership with the American Association of Pharmaceutical Scientists, is designed to deliver volumes authored by opinion leaders and authorities from around the globe, addressing innovations in drug research and development, and best practice for scientists and industry professionals in the pharma and biotech industries. This book series is committed to maintaining the highest level of integrity in the content published. It has a Conflict of Interest policy in place and complies with international, national and/or institutional standards on research involving Human Participants and/or Animals and Informed Consent. The Book series is a member of the Committee on Publication Ethics (COPE) and subscribes to its principles on how to deal with acts of misconduct thereby committing to investigate allegations of misconduct in order to ensure the integrity of research. This book series may use plagiarism detection software to screen the submissions. If plagiarism is identified, the COPE guidelines on plagiarism will be followed.
Content published in this book series is peer reviewed. It solicits reviews from the senior editors of the volume since they are the experts in the field, and they are already known to the authors. In cases, however, where there are particular concerns, a single-blind review system is used where independent external experts are asked for advice. These reviewers know the names of the authors, but the identities of the reviewers are unknown to the authors. Submitted manuscripts are reviewed by at least two experts (the senior editors of the volume and or the consulting editors) as well as the series editor. The reviews evaluate whether the manuscript is scientifically sound and coherent, whether it meets the guidelines regarding style, content, and level of writing. The volume editors decide on the suitability of the manuscript based on their reviews.
Titles in this series are indexed in SCOPUS.